We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.9%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$113B
AUM Growth
+$3.29B
(+3%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
4,363
New
403
Increased
1,677
Reduced
1,774
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$603M |
| 2 |
Entergy
ETR
|
+$403M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.67B |
| 2 |
AABA
Altaba Inc
AABA
|
+$373M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$232M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$229M |
| 5 |
IBM
IBM
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.95% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
2326
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.27M | ﹤0.01% |
59,888
+1,111
| +2% | +$42.7K |
|
|
CHX
2327
DELISTED
ChampionX
CHX
| $2.26M | ﹤0.01% |
67,436
-1,817
| -3% | -$66K |
|
|
XLRN
2328
DELISTED
Acceleron Pharma
XLRN
| $2.26M | ﹤0.01% |
55,017
+7,500
| +16% | +$311K |
|
2329
BHP
BHP
$215B
| $2.26M | ﹤0.01% |
+43,503
| New | +$2.1M |
|
2330
Dolby
DLB
$5.51B
| $2.25M | ﹤0.01% |
34,912
-55,873
| -62% | -$3.56M |
|
2331
Red Robin
RRGB
$145M
| $2.25M | ﹤0.01% |
73,642
+63,678
| +639% | +$1.95M |
|
2332
Trustmark
TRMK
$2.76B
| $2.25M | ﹤0.01% |
67,611
-48,006
| -42% | -$1.62M |
|
2333
CALL
Quanta Services
PWR
$100B
| $2.25M | ﹤0.01% |
+58,800
| New | +$2.23M |
|
2334
Avis
CAR
$4.86B
| $2.24M | ﹤0.01% |
63,765
-6,557
| -9% | -$220K |
|
2335
International Bancshares
IBOC
$4.76B
| $2.24M | ﹤0.01% |
59,397
-5,934
| -9% | -$233K |
|
2336
Nu Skin
NUS
$252M
| $2.23M | ﹤0.01% |
45,242
-52,666
| -54% | -$2.68M |
|
2337
Dine Brands
DIN
$456M
| $2.22M | ﹤0.01% |
23,245
-3,308
| -12% | -$302K |
|
2338
iShares Russell 2000 Value ETF
IWN
$14.3B
| $2.21M | ﹤0.01% |
18,345
-49,743
| -73% | -$6.01M |
|
2339
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $2.21M | ﹤0.01% |
19,860
+7,374
| +59% | +$807K |
|
2340
Heartland Express
HTLD
$948M
| $2.21M | ﹤0.01% |
122,252
+58,806
| +93% | +$1.12M |
|
2341
Arrowhead Research
ARWR
$11.9B
| $2.21M | ﹤0.01% |
83,233
-216,032
| -72% | -$4.74M |
|
2342
Advanced Energy
AEIS
$11.6B
| $2.2M | ﹤0.01% |
39,054
-650
| -2% | -$34.8K |
|
2343
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.55B
| $2.19M | ﹤0.01% |
59,699
+18,155
| +44% | +$663K |
|
|
ATRI
2344
DELISTED
Atrion Corp
ATRI
| $2.19M | ﹤0.01% |
2,573
+188
| +8% | +$166K |
|
2345
BWX Technologies
BWXT
$15.5B
| $2.19M | ﹤0.01% |
41,963
+4,753
| +13% | +$237K |
|
2346
Sensient Technologies
SXT
$5.26B
| $2.18M | ﹤0.01% |
29,721
-5,446
| -15% | -$385K |
|
2347
Bain Capital Specialty
BCSF
$806M
| $2.18M | ﹤0.01% |
+119,223
| New | +$2.27M |
|
2348
KRONOS Worldwide
KRO
$693M
| $2.17M | ﹤0.01% |
141,941
-926
| -0.6% | -$12.9K |
|
2349
PUT
APA Corp
APA
$13.2B
| $2.17M | ﹤0.01% |
75,000
| – | – |
|
2350
Green Dot
GDOT
$743M
| $2.17M | ﹤0.01% |
44,445
-18,351
| -29% | -$999K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2019 Portfolio in Review
As of Q2 2019, Credit Suisse held 4,363 positions worth $113B, up 3% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2019 filing shows 403 new, 1,677 increased, 1,774 reduced and 295 closed positions. Its largest new stake was Alcon: 10,270,934 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- Credit Suisse's largest Q2 2019 buy was Alcon: 10,270,934 shares worth $637M.
- Credit Suisse added most to Entergy in Q2 2019, an estimated $403M increase.
- Credit Suisse's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
- Credit Suisse fully exited iShares Core MSCI Total International Stock ETF in Q2 2019, selling an estimated $232M.
- Credit Suisse's ten largest holdings make up 17% of its $113B portfolio in Q2 2019.
- Credit Suisse opened 403 new positions and closed 295 in Q2 2019.
- Credit Suisse's portfolio value rose 3% quarter-over-quarter to $113B.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.